Eur Rev Med Pharmacol Sci 2022; 26 (17): 6013-6013

DOI: 10.26355/eurrev_202209_29614

Retraction Note: Role of long non-coding RNA SNHG1 in occurrence and progression of ovarian carcinoma

J. Ge, X.-M. Wu, X.-T. Yang, J.-M. Gao, F. Wang, K.-F. Ye

Department of Gynecology, The First People’s Hospital of Yunnan Province, Kunming, China


The article “Role of long non-coding RNA SNHG1 in occurrence and progression of ovarian carcinoma, by J. Ge, X.-M. Wu, X.-T. Yang, J.-M. Gao, F. Wang, K.-F. Ye, published in Eur Rev Med Pharmacol Sci 2018; 22 (2): 329-335–DOI: 10.26355/eurrev_201801_14176–PMID: 29424921” has been retracted by the authors.

After publication, the article was questioned on PubPeer. Concerns were expressed about Figures 2 and 3, raising doubts about the originality of data and the reliability of the published results.

The Publisher apologizes for any inconvenience this may cause

Role of long non-coding RNA SNHG1 in occurrence and progression of ovarian carcinoma

Free PDF Download

To cite this article

J. Ge, X.-M. Wu, X.-T. Yang, J.-M. Gao, F. Wang, K.-F. Ye
Retraction Note: Role of long non-coding RNA SNHG1 in occurrence and progression of ovarian carcinoma

Eur Rev Med Pharmacol Sci
Year: 2022
Vol. 26 - N. 17
Pages: 6013-6013
DOI: 10.26355/eurrev_202209_29614